RHABDOID TUMOUR OF THE KIDNEY

This adverse event was reported 11 times

RHABDOID TUMOUR OF THE KIDNEY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BELZUTIFAN 1 0.0006
1 SORAFENIB 1 0.0000
2 IFOSFAMIDE FOR INJECTION 1 0.0000
3 ETOPOSIDE 3 0.0000
4 MELPHALAN HYDROCHLORIDE 1 0.0000
5 DOXORUBICIN 3 0.0000
6 TORSEMIDE 1 0.0000
7 CARBOPLATIN 3 0.0000
8 TOPIRAMATE 1 0.0000
9 CYCLOPHOSPHAMIDE FOR INJECTION 3 0.0000
See all drugs enriched for association with RHABDOID TUMOUR OF THE KIDNEY